AI-driven analysis of tumor genetics and microenvironment is enabling extremely tailored therapies that strengthen results and reduce Uncomfortable side effects, creating precision medicine a cornerstone of modern oncology  (four). Trials in glioblastoma, pancreatic cancer, and ovarian cancer are underway, with engineered cells remaining more a